‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
The Beacon
Dr. Jack West: Why the Broader FDA Approval of First Pembrolizumab Monotherapy based on KEYNOTE-042 is an Invitation to Inferior Care in Advanced NSCLC
30
00:00:00
/ 00:20:09
30